Legal Opinion

United States v. Pharmacia Fine Chemicals, Inc.

Court of Customs and Patent Appeals

Decided August 24, 1972No. 5467, C.A.D. 1066PublishedCited by 3 opinions

1Opinion of the Court

Hich, Judge.

This appeal is from the decision and judgment of the United States Customs Court, First Division, 66 Cust. Ct. 202, 324 F. Supp. 1113, C.D. 4193 (1971), sustaining appellee’s protest against the classification of “clinical dextran” under TSUS item 439.50 as synthetic drugs and ordering reliquidaition thereof under TSUS item 439.30 as advanced natural drugs. We reverse.

The Merchandise

The importation at bar consists of “clinical dextran,” which is produced from “native dextran,” as it is called, by a hydrolysis process in which hydrochloric acid serves as a catalyst. Native dextran…

2Cases cited4 opinions

  1. Chemirad Corp. v. United StatesUnited States Customs Court · 1970
  2. Sandoz, Inc. v. The United StatesCourt of Customs and Patent Appeals · 1969
  3. Pharmacia Fine Chemicals, Inc. v. United StatesUnited States Customs Court · 1971
  4. Pharmacia Laboratories, Inc. v. United StatesUnited States Customs Court · 1971

3Cited by3 opinions

  1. Montgomery Ward & Co. v. United StatesUnited States Customs Court · 1975
  2. American Rusch Corp. v. United StatesUnited States Customs Court · 1975
  3. Schering Corp. v. United StatesUnited States Court of International Trade · 1981

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API